1. 2022-RA-466-ESGO Long-term responders (LTR) to rucaparib in recurrent ovarian cancer: a sub-group analysis from the rucaparib access (RAP) program in Spain by GEICO. (20th October 2022) Authors: Yubero, Alfonso; Barquín, Aranzazu; Gaba, Lydia; Pajares, Bella; Reche, Piedad; Salvador, Carmen; Alarcón, Jesús; Manso, Luis; Marquez, Raúl; Fuentes, Jose; Madani, Julia; Costenla, Manuel; Gutierrez-Toribio, Maria; Estevez-García, Purificacion; Santaballa, Ana; Sanchez-Lorenzo, Luisa; Calzas, Ju... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2022-RA-909-ESGO AGO-OVAR 28/ENGOT-ov57: niraparib vs niraparib in combination with bevacizumab in patients with carboplatin-taxane based chemotherapy in advanced ovarian cancer (a multicentre randomised phase III trial). (20th October 2022) Authors: Heitz, Florian; Marth, Christian; Henry, Stéphanie; Reuss, Alexander; Cibula, David; Gaba, Lydia; Colombo, Nicoletta; Polleis, Sandra; Harter, Philipp Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 2 Page Start: A277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 442 Should we really abandon minimally invasive surgery in early-stage cervical cancer? oncological results of laparoscopically assisted radical vaginal hysterectomy. (4th December 2020) Authors: Glickman, Ariel Gustavo; Pahisa, Jaume; Ibanez, Blanca Gil; Diaz-Feijoo, Berta; Fusté, Pere; Carreras, Núria; Agustí, Núria; Gaba, Lydia; Pino, Marta Del; Torne, Aureli Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 4 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical implications of the intrinsic molecular subtypes of breast cancer. (1st November 2015) Authors: Prat, Aleix; Pineda, Estela; Adamo, Barbara; Galván, Patricia; Fernández, Aranzazu; Gaba, Lydia; Díez, Marc; Viladot, Margarita; Arance, Ana; Muñoz, Montserrat Journal: Breast Issue: Volume 24(2015)Supplement 2 Page Start: S26 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Corrigendum to "Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study*" [Eur J Cancer 91 (2018) 116–124]. (April 2018) Authors: Valpione, Sara; Carlino, Matteo S.; Mangana, Johanna; Mooradian, Meghan J.; McArthur, Grant; Schadendorf, Dirk; Hauschild, Axel; Menzies, Alexander M.; Arance, Ana; Ascierto, Paolo A.; Giacomo, AnnaMaria Di; de Rosa, Francesco; Larkin, James; Park, John J.; Goldinger, Simone M.; Sullivan, Ryan J.... Journal: European journal of cancer Issue: Volume 93(2018) Page Start: 158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Encephalitis Associated With Immune Checkpoint Inhibitor Treatment in Patients With Melanoma. Issue 5 (11th June 2021) Authors: Martínez-Vila, Clara; Laguna, Juan C.; Segui, Elia; Ruiz, Gustavo; Aya Moreno, Francisco; Fernandez-Morales, Luis M.; Giner Joaquim, Julia; Padrosa, Joan; Fernandez, Laia; Gaba, Lydia; Victoria, Ivan; Arance Fernandez, Ana.M. Journal: Journal of immunotherapy Issue: Volume 44:Issue 5(2021) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. EP064/#192 Potential mechanism for ocular adverse events observed with tisotumab vedotin. (4th December 2022) Authors: Vergote, Ignace; Kim, Stella; Ursell, Paul; Pignata, Sandro; Gonzalez-Martin, Antonio; Randall, Leslie; Melichar, Bohuslav; Madsen, Kristine; Mahner, Sven; Lorusso, Domenica; Henry, Stéphanie; Gaba, Lydia; Salcedo, Theodora; Neff-Laford, Haley; Harris, Jeffrey; Jiang, Joy; Soumaoro, Ibrahima; Jai... Journal: International journal of gynecological cancer Issue: Volume 32(2022)Supplement 3 Page Start: A74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Ipilimumab after progression on anti-PD-1 treatment in advanced melanoma. (December 2016) Authors: Aya, Francisco; Gaba, Lydia; Victoria, Iván; Fernández-Martínez, Aranzazu; Tosca, Mónica; Prat, Aleix; Arance, Ana Journal: Future oncology Issue: Volume 12:Number 23(2016) Page Start: 2683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Motor polyradiculopathy during pembrolizumab treatment of metastatic melanoma. Issue 6 (16th May 2017) Authors: Sepúlveda, Maria; Martinez‐Hernandez, Eugenia; Gaba, Lydia; Victoria, Ivan; Sola‐Valls, Nuria; Falgàs, Neus; Casanova‐Molla, Jordi; Graus, Francesc Journal: Muscle & nerve Issue: Volume 56:Issue 6(2017) Page Start: E162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Pembrolizumab in a BRAF-mutant metastatic melanoma patient following a severe immune-related adverse event with ipilimumab. (June 2016) Authors: Aya, Francisco; Fernández-Martínez, Aranzazu; Gaba, Lydia; Victoria, Iván; Tosca, Mónica; Carrera, Cristina; Prat, Aleix; Arance, Ana Journal: Immunotherapy Issue: Volume 8:Number 6(2016:Jun.) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗